These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [STUDIES ON THE RESISTANCE DYSENTERIAL BACILLI TO ANTIBIOTICS AND CHEMICAL THERAPEUTIC PREPARATIONS]. LEONESCU MB Antibiotiki; 1964 Jul; 9():633-7. PubMed ID: 14232883 [No Abstract] [Full Text] [Related]
4. [A new method for measurement of the sensitivity of tubercle bacilli to antibiotics (the serum method)]. AUDRIN J Rev Tuberc Pneumol (Paris); 1960 Nov; 24():1214-20. PubMed ID: 13685070 [No Abstract] [Full Text] [Related]
5. A new antibiotic against tubercle bacilli (homomycin). KANAI K; SATO N; TACHIBANA T; YANAGISAWA K Jpn J Med Sci Biol; 1956 Jun; 9(3):129-32. PubMed ID: 13376200 [No Abstract] [Full Text] [Related]
6. [Experience with sulfonamides and antibiotics in therapy of shigellosis in children]. MRAVUNAC B; VODOPIJA J Ann Paediatr; 1956 Oct; 187(4):340-50. PubMed ID: 13363114 [No Abstract] [Full Text] [Related]
7. Susceptibility of antibiotic-resistant enteric bacilli to heterologous antibiotics. SCHNEIERSON SS Antibiot Chemother (Northfield); 1961 Aug; 11():515-8. PubMed ID: 13748293 [No Abstract] [Full Text] [Related]
8. The effect of cycloserine on growing and resting tubercle bacilli. HUDGINS PC; PATNODE RA; CUMMINGS MM Am Rev Tuberc; 1955 Nov; 72(5):685-6. PubMed ID: 13259089 [No Abstract] [Full Text] [Related]
9. [Study of the antituberculous activity of kanamycin on 142 strains of tubercle bacilli]. AUDRIN J Ann Inst Pasteur (Paris); 1960 Apr; 98():615-7. PubMed ID: 13795070 [No Abstract] [Full Text] [Related]
11. [Comparison of the therapeutic effectiveness of monomycin, colimycin, mycerin and kanamycin in experimental infections caused by enteropathogenic intestinal bacilli]. SHAPOVALOVA SP Antibiotiki; 1962 Feb; 7():158-61. PubMed ID: 13911339 [No Abstract] [Full Text] [Related]
12. [Bacillary dysentery, antibiotics and sulfaguanidine]. ENGELHARDT HK Munch Med Wochenschr; 1960 Jun; 102():1156-8. PubMed ID: 13820343 [No Abstract] [Full Text] [Related]
13. [Research on sensitivity to antibiotics, to nitrofurantoin and to sulfonamides, of bacteria of the Klebsiella group]. LUTZ A; SCHAEFFER A Ann Inst Pasteur (Paris); 1960 May; 98():657-63. PubMed ID: 14419064 [No Abstract] [Full Text] [Related]
14. Studies on the in vitro and in vivo effect of cycloserine and isoniazid on tubercle bacilli. TRUANT JP Antibiot Annu; 1957-1958; 5():630-4. PubMed ID: 13521871 [No Abstract] [Full Text] [Related]
15. Primary resistance of tubercle bacilli to streptomycin and other antituberculous agents in the province of Quebec. FRAPPIER A; DESJARDINS R; PANISSET M Can Med Assoc J; 1957 Apr; 76(8):653-5. PubMed ID: 13426902 [No Abstract] [Full Text] [Related]
16. Studies on action mechanisms of antituberculous drugs. III. Fundamental studies of cycloserine, especially its effects upon dehydrogenase and catalase of tubercle bacilli. TAKASHINA J Sci Rep Res Inst Tohoku Univ Med; 1957 Mar; 7(3):303-8. PubMed ID: 13432823 [No Abstract] [Full Text] [Related]
18. [Antibiotics for tubercle bacilli]. HESSE E Dtsch Med Rundsch; 1947 Dec; 1(12):450. PubMed ID: 18856947 [No Abstract] [Full Text] [Related]
19. Some experiences of the resistance of the tubercle bacilli on combined treatment with antibiotics. KRISTENSON A Acta Tuberc Scand; 1955; 30(3-4):203-8. PubMed ID: 14387826 [No Abstract] [Full Text] [Related]
20. Antibacterial substances in seed plants active against tubercle bacilli. III. Solanocapsine, the antibacterial alkaloid of Solanum pseudocapsicum. BOLL PM; GOTTSHALL RY; LILLEVIK HA; LUCAS EH Antibiot Annu; 1955-1956; 3():255-9. PubMed ID: 13355277 [No Abstract] [Full Text] [Related] [Next] [New Search]